Şunu aradınız:: hormonska (Slovence - İngilizce)

hormonska kontracepcija
hormonal contraception

hormonska kontracepcija:
hormonal contraceptives:

hormonska kontracepcijska sredstva
hormonal contraceptives

da samo hormonska kontracepcija ni učinkovita
that hormonal contraceptives on their own are not effective

hormonska kontracepcijska sredstva (za uravnavanje rojstev),
hormonal contraceptive agents (birth control medicines),

- hormonska kontracepcijska sredstva (za uravnavanje rojstev),
- repaglinide (used to treat diabetes),

hormonska kontracepcija, npr. kontracepcijske tablete (glejte spodaj).
hormonal contraceptives, such as the pill (see below).

kontracepcijske tablete, hormonska zdravljenja z etinilestradiolom ali hormonska zdravljenja z danazolom,
the contraceptive pill, hormone treatments with ethinylestradiol, or hormone treatments with danazol

kontracepcijske tabletke ali druga hormonska zdravljenja z etinilestradiolom, hormonska zdravljenja z danazolom
the contraceptive pill or other hormone treatments with ethinylestradiol, hormone treatments with danazol

hormonska kontracepcija (na primer tabletka) med zdravljenjem z zdravilom incvivo ni zanesljiva.
a hormonal contraceptive (‘the pill’) may not be reliable during the treatment with incivo.

zaradi zdravila ellaone je lahko redna hormonska kontracepcija, kot so tablete in obliži, začasno manj učinkovita.
ellaone may make regular hormonal contraceptives, like pills and patches, temporarily less effective.

verjetno je, da bodo ta hormonska kontracepcijska sredstva in progestageni prek kompetitivnega delovanja na receptor za progesteron zmanjšali učinkovitost ulipristalacetata.
thus hormonal contraceptives and progestagens are likely to reduce ulipristal acetate efficacy by competitive action on the progesterone receptor.

hormonska zdravila, ki preprečujejo zanositev (kontraceptivi), npr. kontracepcijske tablete, injekcije ali obliži
birth control medicines (contraceptives) containing hormones, such as pills, injections, or patches

Če pa se nadomestna hormonska terapija prekine ali uvede med zdravljenjem z ropinirolom, bo morda potrebno odmerek ropinirola prilagoditi v skladu s kliničnim odzivom.
however, it may be necessary to adjust the ropinirole dose, in accordance with clinical response, if hormone replacement therapy is stopped or introduced during treatment with ropinirole.

poleg tega lahko hormonska kontracepcijska sredstva in progestageni (npr. noretindron ali levonorgestrel) zmanjšajo učinek zdravila esmya.
in addition, hormonal contraceptives and progestagens (e.g. norethindrone or levonorgestrel) are also likely to make esmya less effective.

tako kot druga hormonska kontracepcijska sredstva tudi zdravilo ioa ne varuje pred okužbo z virusom hiv (aids) ali katero drugo spolno prenosljivo boleznijo.
ioa, like other hormonal contraceptives, does not protect against hiv infection (aids) or any other sexually transmitted disease.

bikalutamid je bil uporabljen kot takojšnja hormonska terapija ali kot adjuvantna terapija poleg radikalne prostatektomije ali radioterapije (v prvi vrsti z zunanjim obsevanjem).
bicalutamide 150 mg was studied as a treatment for patients with localized (t1-t2, n0 or nx, m0) or locally advanced (t3-t4, any n, m0; t1-t2, n+, m0) non-metastatic prostate cancer, in a combined analysis of 3 placebo-controlled double-blind studies in 8,113 patients, where the product was given as immediate hormone therapy or as adjuvant to radical prostatectomy or radiotherapy (primarily external beam radiation).

Če pa uporablja druga hormonska kontracepcijska sredstva, ki se ne jemljejo peroralno, mora v naslednjih 7 dnevih uporabljati še dodatno, nehormonsko kontracepcijsko metodo in upoštevati navodila za uporabo kontraceptiva.
in the case of non-oral hormonal contraceptives, the patient must use an additional non hormonal contraceptive method for the next 7 days and refer to the advice in the package leaflet of the product.

trenutno ni znano, ali lenvatinib lahko zmanjša učinkovitost hormonskih kontracepcijskih sredstev, zato naj ženske, ki uporabljajo peroralna hormonska kontracepcijska sredstva, dodatno uporabijo še pregradno metodo kontracepcije.
it is currently unknown whether lenvatinib may reduce the effectiveness of hormonal contraceptives, and therefore women using oral hormonal contraceptives should add a barrier method.

v teh primerih utegne biti primerneje izvesti posebne toksikološke študije, ki so zasnovane za raziskavo teh učinkov (npr. imunotoksičnost, nevrotoksičnost, hormonska aktivnost), ali
in such cases it may also be more appropriate to perform specific toxicological studies that are designed to investigate these effects (e.g. immunotoxicity, neurotoxicity, hormonal activity), or